International Business News - SUPG http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Shares of Celgene Corp. climbed modestly Wednesday after Cowen and Co. upgraded the stock based on its value and strong potential for the biotechnology company's products, despite a sinking broader economy. http://www.ibtimes.com/articles/20081008/celgene-shares-rise-as-cowen-upgrades-stock.htm Wed, 08 Oct 2008 21:08:09 EDT SuperGen Inc. said Thursday the Food and Drug Administration granted its developing brain-cancer treatment special status, giving it financial and market incentives. http://www.ibtimes.com/articles/20080807/supergen-drug-candidate-gets-special-designation.htm Thu, 07 Aug 2008 09:24:34 EDT The Nasdaq 100 index rose Tuesday as shares of biopharmaceutical company Celgene Corp. advanced after competitor SuperGen Inc.'s bone marrow cancer drug Dacogen failed a late-stage European study. http://www.ibtimes.com/articles/20080701/nasdaq-100-leaders-and-laggards-celg-uaua.htm Tue, 01 Jul 2008 16:45:37 EDT Among the earnings projection stories for Tuesday, July 1, from AP Financial News: NEW YORK (AP)--Chinese automotive supplier Wonder Auto Technology Inc. said Tuesday it expects its second-quarter profit and sales to be up from the same quarter last year. http://www.ibtimes.com/articles/20080701/outlook-roundup-wonder-auto-supergen.htm Tue, 01 Jul 2008 14:05:42 EDT The Standard & Poor's 500 declined in midday trading on Tuesday, with the biggest fall taken by shares of Fortune Brands Inc., after the company lowered its outlook. http://www.ibtimes.com/articles/20080701/midday-leaders-laggards-s-p-500.htm Tue, 01 Jul 2008 12:24:05 EDT Shares of biotechnology company Celgene Corp. advanced Tuesday as a potential competitor to its bone-marrow cancer treatment in Europe failed a late-stage clinical trial. http://www.ibtimes.com/articles/20080701/celgene-shares-rise-as-rivals-drug-fails-study.htm Tue, 01 Jul 2008 18:43:15 EDT SuperGen Inc. said Tuesday its bone marrow disorder drug Dacogen failed in a late-stage European clinical trial, which pressured SuperGen shares and boosted Celgene Corp., which makes a rival drug, Vidaza. http://www.ibtimes.com/articles/20080701/out-of-the-gate-supergen-drug-trial-fails.htm Tue, 01 Jul 2008 10:46:34 EDT Pharmaceutical company SuperGen Inc. on Tuesday reaffirmed its 2008 financial outlook after reporting a failed late-stage clinical trial for its drug candidate Dacogen. http://www.ibtimes.com/articles/20080701/supergen-reaffirms-2008-outlook-following-study.htm Tue, 01 Jul 2008 10:16:05 EDT Pharmaceutical company SuperGen Inc. said Tuesday its drug candidate Dacogen was not effective in treating a type of bone marrow disorder in a late-stage study. http://www.ibtimes.com/articles/20080701/supergen-drug-fails-late-stage-bone-marrow-study.htm Tue, 01 Jul 2008 10:15:19 EDT